Eupraxia Pharmaceuticals Inc【EPRX】株式ニュース | ADVFN

US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Eupraxia Pharmaceuticals Inc (EPRX)
Eupraxia Pharmaceuticals Inc (EPRX) ニュース

Eupraxia Pharmaceuticals Inc (EPRX)

3.18

0.07

(2.25%)

終了 12月27日 6:00AM

3.65

0.47

(14.78%)

取引時間後: 8:41AM

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Eupraxia's DiffuSphere™ Technology Demonstrates Targeted Drug Release while Minimizing Systemic Exposure for a Period of More Than Six Months

Eupraxia's DiffuSphere™ Technology Demonstrates Targeted Drug Release while Minimizing Systemic...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Eupraxia Pharmaceuticals to Present at American College of Rheumatology Convergence 2024 Annual Meeting

Eupraxia Pharmaceuticals to Present at American College of Rheumatology Convergence 2024 Annual Meeting PR...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Eupraxia Pharmaceuticals' CEO Dr. James Helliwell to Participate in Webinar Event, "Eosinophilic Esophagitis: The Emerging Digestive Disorder Frequently Misdiagnosed", on November 15, 2024

Eupraxia Pharmaceuticals' CEO Dr. James Helliwell to Participate in Webinar Event, "Eosinophilic...

Eupraxia Pharmaceuticals Announces Positive Data from Fifth Cohort of RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis

Eupraxia Pharmaceuticals Announces Positive Data from Fifth Cohort of RESOLVE Phase 1b/2a Trial of EP-104GI...

Form D - Notice of Exempt Offering of Securities

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Eupraxia Pharmaceuticals Reports Third Quarter 2024 Financial Results

Eupraxia Pharmaceuticals Reports Third Quarter 2024 Financial Results PR Newswire VICTORIA, BC, Nov. 7, 2024...

Form SC 13D - General Statement of Acquisition of Beneficial Ownership

Eupraxia Pharmaceuticals Announces that it has Closed a Non-Brokered Private Placement of C$44.5 Million

Eupraxia Pharmaceuticals Announces that it has Closed a Non-Brokered Private Placement of C$44.5 Million PR...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Eupraxia Pharmaceuticals to Present at American College of Gastroenterology Annual Scientific Meeting 2024

Eupraxia Pharmaceuticals to Present at American College of Gastroenterology Annual Scientific Meeting 2024 PR...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

RealDutch

RealDutch 4分前

Laxmi, stop sending crappy emails to the entire shareholder base.

Hopeforthefuture3

Hopeforthefuture3 5分前

Froggmister, thanks for posting more from the Liau WCM q&a. I am a total believer in what Dr. Liau says and have been for a decade. When in this presentation and other presentations she says there are challenges with mouse models I believe her. In this one she said "there's just no good mouse model"

LoveItInBishop

LoveItInBishop 5分前

SES QSI QMMM LODE

maperatpogi

maperatpogi 5分前

I agree.
$IGPK $JFHE

alertmeipp

alertmeipp 6分前

I've already written off the value of 235 and the patent suit in my investment case. If any positive surprises come from them, it would just be a bonus.
That said, all these discussions reinforce our belief that this company is significantly undervalued compared to its current trading price—m

zerosnoop

zerosnoop 6分前

So CONTRACTS have been issued. This must mean waiting for sign offs. I'm glad I know how to read & understand English. Tic toc tic toc. Only uneducated fools with a low IQ who are SHORT won't understand this hah hah. The PROVEN AOT is going GLOBAL.

Expansion into Global Markets

Lakota-45

Lakota-45 7分前

Yeah, you & me both, . .

It amazes me that so many still haven't figured it out yet !!!
I'm just guessing that the "True Market Value" of
the ( 15% ) will be a "Game changer !!!

~ Oh well, will just have to wait & see !!!

~ $WDLF ~

havnagoodtime

havnagoodtime 8分前

Actually, you can PM an admin and ask to have a post removed due to making a mistake and that mistaken post is off topic. Try it.

zerosnoop

zerosnoop 9分前

Oh so the debt to Temple University is going to get written off. Just what the paid bashers & naked shorters didn't want to hear before the xmas break hah hah. All the ducks are being lined up now. The SHORT SQUEEZE will be fun to watch. The PROVEN AOT is a "GAME CHANGER" for the oil industry.

NoMoDo

Seriously? I have no idea. I will tell you that I expect the price to rise considerably from here. I will also tell you that I personally plan on selling as much as half my position on the way up to reduce my risk. My investment strategy is not yours, nor anyone else's. Watch the next move up a

investisseur101

investisseur101 11分前

Humm yes you are right..i saw this on stocktwit..people can tell anything..now i cant delete this ..bad

zerosnoop

zerosnoop 11分前

As per Sano's other post below, he is coming to the QS shareholders meeting in February 2025. I can't wait to see Sano take on ceo & cfo Kyte, IF Sano actually shows up.

When QS held past shareholders meetings in Santa Barbara, in one's very own backyard, I know who went missing in ac

3331

BIEL: Roaring Kitty has dissolved his entire stake in pet products retailer Chewy on Oct 29, 2024.

Need to buy some BIEL instead Kitty, RecoveryRx Veterinary will be huge!

https://vetphysiodevon.com/vet-recovery-rx#:~:text=An%20innovation%20in%20drug%2Dfree,energy%20to%

Steady_T

Steady_T 12分前

Based on what? Short squeeze could be epic here.

zerosnoop

zerosnoop 12分前

As per Sano's post below, he is coming to the QS shareholders meeting. I can't wait to see Sano take on engineer Gallagher, IF Sano shows up.

When QS held past shareholders meetings in Santa Barbara, in one's own backyard, I know who went missing in action time & time again. I wouldn'

EmpressMonk25

EmpressMonk25 13分前

That moment when you realize your side of the fence isn't looking so good.

I better get outta here...LOL!

jake12

jake12 13分前

You only complain when the price goes up at the end of the day! What’s wrong with you?

shajandr

shajandr 15分前

Merry Christmas from Juror 16 (nott to be CONfused with Clint Eastwood's Juror #2).

Under the wrapping paper, in DaBoxx is a bill for several more million$ in legal fee$ and expert witness expense$ - trials are very expensive. And it's nott possible to reliably predict jury

RealDutch

RealDutch 15分前

Laxmi is still digging that hole for himself. Deeper and deeper...

Alley-oop

Alley-oop 17分前

What would be the price range?

NoMoDo

NoMoDo 17分前

Yet you couldn't see that the stock was going to go up 4000% from .0001 even though I told you. You can't see that we will see another 200% within a month. Crazy what we are able to see... and what we aren't.

investisseur101

investisseur101 17分前

I imagine than yes , On stocktwit they are talking about this

dinogreeves

dinogreeves 18分前

Riding on 28,000 shares from 30 cents average. Looking fantastic for a run to $3.00

Genz2

https://www.wpri.com/target-12/deloitte-hit-with-class-action-lawsuits-over-ribridges-cyberattack/amp/

The world needs Wave!!!

Eupraxia Pharmaceuticals

AMUNDI PR1Z INAV

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約